Immune Enhancement of Yellow Fever Virus Neurovirulence for Mice: Studies of (original) (raw)
Immune Enhancement of Yellow Fever Virus Neurovirulence for Mice: Studies of Mechanisms Involved
Ernest Gould
Journal of General Virology, 1988
View PDFchevron_right
Antibody-dependent Enhancement of Yellow Fever and Japanese Encephalitis Virus Neurovirulence
Ernest Gould
Journal of General Virology, 1989
View PDFchevron_right
Neutralizing (54K) and Non-neutralizing (54K and 48K) Monoclonal Antibodies against Structural and Non-structural Yellow Fever Virus Proteins Confer Immunity in Mice
Ernest Gould
Journal of General Virology, 1986
View PDFchevron_right
Antibody-mediated Early Death in vivo after Infection with Yellow Fever Virus
Ernest Gould
Journal of General Virology, 1986
View PDFchevron_right
Reduction of Yellow Fever Virus Mouse Neurovirulence by Immunization with a Bacterially Synthesized Non-structural Protein (NS1) Fragment
Ernest Gould
Journal of General Virology, 1988
View PDFchevron_right
Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters
Robert Tesh
The American journal of tropical medicine and hygiene, 2007
View PDFchevron_right
CD8+ T Cells Complement Antibodies in Protecting against Yellow Fever Virus
Christina Fenger, Jan Christensen, Allan R Thomsen
Journal of immunology (Baltimore, Md. : 1950), 2015
View PDFchevron_right
A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection
Mikhail Khoretonenko
PLoS Pathogens, 2009
View PDFchevron_right
Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice
John Mackenzie
Journal of General Virology, 2003
View PDFchevron_right
Importance of the Antibody Response in the Outcome of Virus-Induced Diseases of the Central Nervous System
Robert Knobler
Viruses, Immunity, and Mental Disorders, 1987
View PDFchevron_right
Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys
Marcos Freire, Renato Marchevsky
Virology, 2003
View PDFchevron_right
Intrathecal antibody production in two cases of yellow fever vaccine associated neurotropic disease in Argentina
Corina Nemirovsky
Journal of Medical Virology, 2011
View PDFchevron_right
Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies
Junko Kimura-Kuroda
Journal of Immunology, 1988
View PDFchevron_right
Antigenic analysis of yellow fever virus glycoproteins: Use of monoclonal antibodies in enzyme-linked immunosorbent assays
Ernest Gould
Journal of Virological Methods, 1986
View PDFchevron_right
Experimental Yellow Fever Virus Infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, Biochemical, and Immunologic Studies
Robert Tesh
The Journal of Infectious Diseases, 2001
View PDFchevron_right
Neutralizing and Non-neutralizing Monoclonal Antibodies to the E2 Glycoprotein of Semliki Forest Virus Can Protect Mice from Lethal Encephalitis
M. Harmsen
Journal of General Virology, 1983
View PDFchevron_right
CD8+ T cells complement antibodies in protection against yellow fever virus
Michael Rasmussen, Maria Bassi, Jan Christensen
View PDFchevron_right
Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses
Robert Tesh
The American journal of tropical medicine and hygiene, 2003
View PDFchevron_right
Increased cellular immunity against host cell antigens induced by vacciniavirus
Ulrich Koszinowski
Archiv f�r die gesamte Virusforschung, 1974
View PDFchevron_right
Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain
Veronique Barban
Biologicals, 2013
View PDFchevron_right
Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever
Carla Pagliari
Reviews in Medical Virology, 2013
View PDFchevron_right
Antibody-mediated clearance of viruses from the mammalian central nervous system
Bernhard F Dietzschold
Trends in Microbiology, 1993
View PDFchevron_right
Neurotropism of Swine Haemagglutinating Encephalomyelitis Virus (Coronavirus) in Mice Depending upon Host Age and Route of Infection
Koujiro Tohyama
Journal of Comparative Pathology, 2004
View PDFchevron_right
Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937)
Ferdinando Liprandi
Archives of Virology, 1983
View PDFchevron_right
The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus
Harm Snippe
Immunology, 1986
View PDFchevron_right
A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs
Meret Ricklin
Viruses, 2017
View PDFchevron_right
Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses
Ernest Gould
Archives of Virology, 1991
View PDFchevron_right
Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model
SHAIKH TERKIS ISLAM PAVEL
View PDFchevron_right
Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys
Marcos Freire
Brazilian Journal of Medical and Biological Research, 2005
View PDFchevron_right
Viruses and antibody response: An update
P L Ogra
Clinical Immunology Newsletter, 1985
View PDFchevron_right
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures
Marcos Freire
Vaccine, 2015
View PDFchevron_right
Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination
ricardo caminha
Clinical and Vaccine Immunology, 2009
View PDFchevron_right